State Street’s Traws Pharma TRAW Stock Holding History

State Street’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$47.2K	Hold	25,802	–	–	﹤0.01%	4134
2025 Q4	$29.2K	Buy	+25,802	New	+$57.4K	﹤0.01%	4212
2024 Q3	–	Sell	-2,404	Closed	-$26.8K	–	4347
2024 Q2	$26.8K	Buy	2,404 +292	+14%	+$4.71K	﹤0.01%	4241
2024 Q1	$53.3K	Hold	2,112	–	–	﹤0.01%	4149
2023 Q4	$39.4K	Hold	2,112	–	–	﹤0.01%	4243
2023 Q3	$38.1K	Hold	2,112	–	–	﹤0.01%	4342
2023 Q2	$62.3K	Hold	2,112	–	–	﹤0.01%	4362
2023 Q1	$38.6K	Hold	2,112	–	–	﹤0.01%	4568
2022 Q4	$33.9K	Hold	2,112	–	–	﹤0.01%	4641
2022 Q3	$47K	Hold	2,112	–	–	﹤0.01%	4672
2022 Q2	$70K	Buy	2,112 +96	+5%	+$3.24K	﹤0.01%	4650
2022 Q1	$93K	Hold	2,016	–	–	﹤0.01%	4662
2021 Q4	$128K	Hold	2,016	–	–	﹤0.01%	4516
2021 Q3	$193K	Sell	2,016 -2,588	-56%	-$333K	﹤0.01%	4370
2021 Q2	$798K	Buy	4,604 +4,356	+1,756%	+$986K	﹤0.01%	3706
2021 Q1	$93K	Buy	+248	New	+$93.5K	﹤0.01%	3908
2014 Q2	–	Sell	-1	Closed	-$453K	–	3676
2014 Q1	$453K	Hold	1	–	–	﹤0.01%	3376
2013 Q4	$708K	Hold	1	–	–	﹤0.01%	3307
2013 Q3	$1.2M	Buy	+1	New	+$1.43M	﹤0.01%	3215

Other funds holding TRAW

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $273M AUM

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PWM

Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street's TRAW Position: Q1 2026 in Review

State Street held its Traws Pharma (TRAW) position steady in Q1 2026 at 25,802 shares worth $47.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4134.

State Street first reported a position in TRAW in Q3 2013 and has held it in 19 quarters since. The position peaked at $1.2M in Q3 2013. 28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

State Street held 25,802 shares of Traws Pharma worth $47.2K as of Q1 2026.
State Street left its Traws Pharma share count unchanged in Q1 2026.
Traws Pharma made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4134 holding.
State Street first reported a position in Traws Pharma in Q3 2013 and has held it in 19 quarters since.
State Street's Traws Pharma position peaked at $1.2M in Q3 2013.
28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.